DK445784D0 - Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf - Google Patents

Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf

Info

Publication number
DK445784D0
DK445784D0 DK445784A DK445784A DK445784D0 DK 445784 D0 DK445784 D0 DK 445784D0 DK 445784 A DK445784 A DK 445784A DK 445784 A DK445784 A DK 445784A DK 445784 D0 DK445784 D0 DK 445784D0
Authority
DK
Denmark
Prior art keywords
fluorenylalkylimidazole
procedures
derivatives
preparing
fluorenylalkylimidazole derivatives
Prior art date
Application number
DK445784A
Other languages
English (en)
Other versions
DK445784A (da
Inventor
David Wayne Robertson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK445784D0 publication Critical patent/DK445784D0/da
Publication of DK445784A publication Critical patent/DK445784A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK445784A 1983-09-21 1984-09-19 Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf DK445784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,469 US4533670A (en) 1983-09-21 1983-09-21 Anti-convulsant fluorenylalkylimidazole derivatives, compositions, and method of use

Publications (2)

Publication Number Publication Date
DK445784D0 true DK445784D0 (da) 1984-09-19
DK445784A DK445784A (da) 1985-04-24

Family

ID=24130180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK445784A DK445784A (da) 1983-09-21 1984-09-19 Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf

Country Status (9)

Country Link
US (1) US4533670A (da)
EP (1) EP0138415A2 (da)
JP (1) JPS60136569A (da)
KR (1) KR870000233B1 (da)
DK (1) DK445784A (da)
GB (1) GB2146991B (da)
GR (1) GR80388B (da)
HU (1) HUT35251A (da)
IL (1) IL72999A0 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8511344D0 (en) * 1985-05-03 1985-06-12 Ici Plc Heterocyclic compounds
JPH03115267A (ja) * 1989-09-28 1991-05-16 Maruho Kk プロピオフエノン誘導体、その製造方法、それを含む中枢性筋弛緩剤および抗痙攣剤
CA2213246A1 (en) * 1995-03-01 1996-09-06 Yamanouchi Pharmaceutical Co., Ltd. Imidazole derivatives and medicinal composition thereof
US6110499A (en) * 1997-07-24 2000-08-29 Alza Corporation Phenytoin therapy
US11054743B2 (en) 2015-12-15 2021-07-06 Changzhou Tronly Advanced Electronic Materials Co., Ltd. Fluorene polyfunctional photoinitiator and preparation and use thereof, and photosensitive resin composition containing fluorene photoinitiator and use thereof
EP3514135B1 (en) 2016-09-13 2021-04-21 Changzhou Tronly Advanced Electronic Materials Co., Ltd. Fluorene photoinitiator, preparation method therefor, photocurable composition having same, and use of same in photocuring field
JP7032416B2 (ja) * 2017-02-17 2022-03-08 常州強力先端電子材料有限公司 フルオレニルアミノケトン類光開始剤、その調製方法及びフルオレニルアミノケトン類光開始剤を含有するuv光硬化性組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826837A (en) * 1970-02-03 1974-07-30 Bayer Ag 9-azolyl-(1)-fluorene-9-carboxylic acid derivatives as an anti-mycotic agent
DE2053080C3 (de) * 1970-10-29 1979-08-23 Bayer Ag N-substituierte Imidazole und ihre Verwendung als Arzneimittel
US3993815A (en) * 1974-10-07 1976-11-23 Avery Products Corporation Anaerobic pressure sensitive adhesive stocks
US4036973A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
US4036974A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. 1-{2'-[R'-Thio(oxy)]-3'-(R2 -thio(oxy)]propyl}imidazoles
US4036970A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
US4045568A (en) * 1975-07-28 1977-08-30 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
US4036975A (en) * 1975-07-28 1977-07-19 Xyntex (U.S.A) Inc. 1-[2-(1-Adamantyl)-2-(R-thio)ethyl]imidazoles and 1-[2-(1-adamantyl)-2-(R-oxy)ethyl]imidazoles
US4038409A (en) * 1976-03-01 1977-07-26 Syntex (U.S.A.) Inc. 1-phenethylimidazoles
US4039677A (en) * 1976-03-01 1977-08-02 Syntex (U.S.A.) Inc. Novel 1-phenethylimidazoles
US4172141A (en) * 1976-03-17 1979-10-23 Syntex (U.S.A.) Inc. N-(naphthylethyl)imidazole derivatives
US4150153A (en) * 1977-05-13 1979-04-17 Syntex (U.S.A.) Inc. 1-(Naphthylethyl)imidazole derivatives
IT1097314B (it) * 1978-07-26 1985-08-31 Recordati Chem Pharm Derivati dell'imidazolo ad attivita' anticonvulsivante
DE2851143A1 (de) * 1978-11-25 1980-06-04 Bayer Ag Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1173449A (en) * 1979-11-16 1984-08-28 Adolf Hubele 1-¬2-(4-diphenyl)ethyl|-1h-azolylketals
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use

Also Published As

Publication number Publication date
KR850002256A (ko) 1985-05-10
GB8423847D0 (en) 1984-10-24
US4533670A (en) 1985-08-06
GB2146991A (en) 1985-05-01
EP0138415A2 (en) 1985-04-24
GR80388B (en) 1985-01-17
JPS60136569A (ja) 1985-07-20
DK445784A (da) 1985-04-24
GB2146991B (en) 1987-04-15
IL72999A0 (en) 1984-12-31
HUT35251A (en) 1985-06-28
KR870000233B1 (ko) 1987-02-18

Similar Documents

Publication Publication Date Title
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK493583D0 (da) Azolderivater og fremgangsmade til fremstilling deraf
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
DK566484A (da) Dihydropyridinderivat og fremgangsmaade til fremstilling deraf
DK256485D0 (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK157683D0 (da) N-phosphonomethylglycinderivater og fremgangsmade til fremstilling og anvendelse deraf
DK572583D0 (da) Pyridinderivater og fremgangsmaade til fremstilling deraf
DK621484A (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK445784A (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK135684D0 (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK26384D0 (da) Toxoplasmosefaktor og fremgangsmade til fremstilling deraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK90083D0 (da) Isoxazolopyrimidinderivater og fremgangsmade til fremstilling deraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK14685A (da) Thioketenderivater og fremgangsmaade til fremstilling deraf
DK284184A (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
DK596884A (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK47184D0 (da) Benzazepin-derivater og fremgangsmaade til fremstilling deraf
DK550883A (da) Hexahydrodioxopyrimidiner og fremgangsmaade til fremstilling deraf